Integra LifeSciences Services
9
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
22.2%
2 terminated/withdrawn out of 9 trials
77.8%
-8.7% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Clinical Outcome of Defect Reconstruction Using IDRT Single Layer : Results From a Prospective Multicentric Trial
Role: lead
Evaluation of Integra® Artificial Dermis for the Treatment of Leg Ulcers
Role: lead
Observational Study of Total Ankle Arthroplasty and Tibiotalar Arthrodesis
Role: lead
Short Term Follow-up of Patient Implanted With the Proximal Interphalangeal Implant
Role: lead
Short Term Follow-up of Patent Implanted With the B-BOP Lock Plate
Role: lead
Stabilization of Trochanteric Fracture Using a Screw-plate TRAUMAX
Role: lead
Short Term Follow-up of Patient Implanted With the Metatarso-Phalangeal Prosthesis METIS®
Role: lead
Follow-up of Patient Implanted With the Staple ASTUS®
Role: lead
HINTEGRA Total Ankle Prosthesis Follow-up
Role: lead
All 9 trials loaded